Topic

All

31
Jul
2023

Lessons For Biopharma from a Healthcare AI Pioneer

As drug developers consider how to leverage AI and other emerging digital and data technologies, they look to related businesses, such as healthcare systems, for lessons and learning.    We would be hard-pressed to find a better guide to AI in healthcare than Ziad Obermeyer, an emergency room physician and health science researcher at the University of California-Berkeley. His research...
Read More
10
Jul
2023

Detecting Cancer Early When It’s Most Treatable: Kevin Conroy on The Long Run

Today’s guest on The Long Run is Kevin Conroy. Kevin is the chairman and CEO of Madison, Wis.-based Exact Sciences. Exact Sciences has grown over the past decade into a success story for cancer screening and diagnosis. It’s best known for marketing the noninvasive Cologuard test that screens people for colorectal cancer. It also markets the Oncotype DX test that’s...
Read More
27
Jun
2023

Becoming a Biotech CEO: Jodie Morrison on The Long Run

Today’s guest on The Long Run is Jodie Morrison. Jodie is the acting CEO at Waltham, Mass.-based Q32 Bio. It’s a company developing treatments for autoimmune and inflammatory diseases. It has an antibody in development with Horizon Therapeutics aimed at IL-7 receptor alpha, in Phase II for the treatment of atopic dermatitis. It also has wholly-owned programs aimed at the...
Read More
27
Jun
2023

Biopharma Has a Primary Care Problem

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more.   Subscribe Now   Sign in to your account.